Reports

The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

Canadian Cardiovascular Congress 2006

Reducing Lifetime Cardiovascular Disease Event Rates: Emphasizing Early Risk Factor Modification and Intensive Intervention

Vancouver, British Columbia / October 21-25, 2006

Vancouver - Atherosclerosis typically begins between 10 and 20 years of age, with clinical manifestations developing at approximately 50 years of age. Early intensive risk factor modification aimed at altering the course of cardiovascular...

16th Annual Congress of the European Respiratory Society

Restoring Quality of Life for Patients with Chronic Obstructive Pulmonary Disease

Munich, Germany / September 2-6, 2006

Munich - Data presented here suggest that clinical studies of treatments for chronic obstructive pulmonary disease (COPD) are now beginning to measure what is important to the patient. Rather than laboratory measures of pulmonary function,...

16th Annual Congress of the European Respiratory Society

Novel Implications for Control of Chronic Obstructive Pulmonary Disease and Asthma

Munich, Germany / September 2-6, 2006

In asthma as in chronic obstructive pulmonary disease (COPD), the immediate goal of an effective therapeutic regimen is to prevent acute exacerbations, a goal that also has important implications for inhibiting progressive bronchial...

16th Annual Congress of the European Respiratory Society

Inflammation: The Scientific and Clinical Link in Asthma and Allergic Rhinitis

Munich, Germany / September 2-6, 2006

According to Dr. Leif Bjermer, Department of Clinical Medicine, Division of Lung Medicine, University Hospital, Lund, Sweden, “There is a distinct pathophysiologic link between upper and lower airways and having rhinitis is a risk...

16th Annual Congress of the European Respiratory Society (ERS)

Improving Health Outcomes in Asthma and Chronic Obstructive Pulmonary Disease

Munich, Germany / September 2-6, 2006

Editorial Overview J. Mark FitzGerald, MD, FRCPC, FRCPI, FACCP Director, Centre for Clinical Epidemiology and Evaluation Vancouver Coastal Health Research Institute Head, Division of Respiratory Medicine Professor of Medicine, University...

13th World Conference on Tobacco or Health

Combining Behavioural Counselling with Pharmacological Therapy: A Viable Formula for Smoking Cessation

Washington, DC / July 12-15, 2006

Washington, DC - Double-blind controlled trials have demonstrated that the relative specificity of pharmacologic therapies directed at central mediators of tobacco addiction appear to promote longer remission from smoking, according to...

7th International Congress on Pediatric Pulmonology

Issues in Managing Asthma in Children

Montreal, Quebec / July 8-11, 2006

Exercise-induced Asthma According to Dr. Soo-Jong Hong, Department of Pediatrics, Asan Medical Center, College of Medicine, Ulsan University, Seoul, Korea, “Asthma triggered by activity is very common in children and about 80% of my...

42nd Annual Meeting of the American Society of Clinical Oncology

The Role of Biomarkers and Monoclonal Antibodies in Lung Cancer

Atlanta, Georgia / June 2-6, 2006

Atlanta - Identifying patients who are more likely to respond to treatment is an important guiding principle in oncology, sparing those who are less likely to respond any unnecessary toxicity. In a subset of patients enrolled in the ECOG...

42nd Annual Meeting of the American Society of Clinical Oncology

Update on Targeted Therapies for Non-small Cell Lung Cancer

Atlanta, Georgia / June 2-6, 2006

Atlanta - The first real improvement in the treatment of advanced non-small cell lung cancer (NSCLC) to emerge in decades has been the development of targeted therapies. One of these is erlotinib, an orally active, potent and selective...

PAGE 8 OF 9   1 2 3 4 5 6 7 8 9